Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $121
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.
